Tomas Mlcoch

5PUBLICATIONS
9CO-AUTHORS
Cross-sectional analysisDisease surveillanceMedical biotechnology not elsewhere classifiedRegenerative medicine (incl. stem cells)Epidemiological methods
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Sep 19, 2022
Indirect treatment comparison and cost-minimization analysis of riociguat versus selexipag in patients with pulmonary arterial hypertension.

Eva Ornstová, Jan Tužil, Kateřina Chadimová

|Oct 02, 2021
Time in remission as an alternative outcome measure for rheumatoid arthritis: a 10-year prospective study of 2618 new users of anti-TNF.

Jan Tužil, Tomáš Mlčoch, Jakub Závada

|Jan 11, 2021
Cost-Effectiveness Analysis of Parenteral Methotrexate for the Treatment of Crohn's Disease.

Tomas Mlcoch, Barbora Decker, Tomas Dolezal

|Nov 19, 2019
Short-term response in new users of anti-TNF predicts long-term productivity and non-disability: analysis of Czech ATTRA ankylosing spondylitis biologic registry.

Jan Tužil, Tomáš Mlčoch, Jitka Jirčíková

|Nov 23, 2017
Mapping Quality of Life (EQ-5D) from DAPsA, Clinical DAPsA and HAQ in Psoriatic Arthritis.

Tomas Mlcoch, Jan Tuzil, Liliana Sedova

Pageof 1

Frequent Collaborators

4 joint publications

Jan Tuzil

2 joint publications

Jakub Závada

2 joint publications

Karel Pavelka

1 joint publications

Lucie Nekvindová